期刊文献+

术中雷替曲塞腹腔灌洗在结直肠癌根治术后预防复发的效果 被引量:4

Effect of intra-operative peritoneal lavage with Raltitrexed on preventing recurrence after radical resection of colorectal carcinoma
原文传递
导出
摘要 目的探讨术中雷替曲塞腹腔灌洗在结直肠癌根治术后预防复发的效果及对肿瘤标志物水平的影响。方法收集2015年1月至12月自贡市第一人民医院收治的64例T4大肠癌患者随机分为实验组和对照组(各32例)。两组患者皆行结直肠癌根治术,对照组患者术中以生理盐水灌注腹腔,实验组患者术中则以雷替曲塞腹腔灌洗,比较两组患者治疗前后肿瘤标志物、毒性指标、相关临床指标以及1年复发转移、生存率、术后不良反应率。结果治疗后,实验组患者血管内皮生长因子(VEGF)[(324.40±66.73)pg/ml vs(420.76±34.92)pg/ml]、骨桥蛋白(OPN)[(57.12±16.35)ng/ml vs(80.20±21.35)ng/ml]、癌胚抗原(CEA)[(3.18±1.04)ng/ml vs(5.84±1.80)ng/ml]与糖类抗原199(CA199)[(4.16±2.15)μg/ml vs(8.33±3.47)μg/ml]水平均显著低于对照组(P均<0.01),1年复发转移率明显低于对照组(6.25%vs 25.00%,χ2=4.267,P=0.039)。结论术中雷替曲塞腹腔灌洗在结直肠癌根治术后预防复发的效果显著,可明显降低患者血清VEGF、OPN、CEA及CA199水平,降低1年复发转移率。 Objective To investigate the effect of intra-operative peritoneal lavage with Raltitrexed on preventing recurrence and the level of tumor markers after radical resection of colorectal carcinoma. Methods A total of 64 T4 colorectal carcinoma patients who were treated in Zigong First People's Hospital from January 2015 to December 2015 were divided into experimental group and control group randomly(32 cases each). Both groups were treated with radical resection of colorectal carcinoma. In the control group,patients were received intra-operative peritoneal lavage with saline,and the patients in the experimental group were treated with Raltitrexed instead. The pre-and post-operative level of tumor markers,toxic indicators and related clinical indicators,recurrence and survival after 1 year and rate of postoperative adverse reactions were compared between the two groups. Results The postoperative level of vascular endothelial growth factor(VEGF),osteopontin(OPN),carcino-embryonic antigen(CEA) and carbohydrate antigen(CA)-199 in experimental group were all lower than those in control group [(324. 40 ± 66. 73) pg/ml vs(420. 76 ± 34. 92) pg/ml,(57. 12 ± 16. 35) ng/ml vs(80. 20 ± 21. 35) ng/ml,(3. 18 ± 1. 04) ng/ml vs(5. 84 ± 1. 80) ng/ml,(4. 16 ± 2. 15) μg/ml vs(8. 33 ± 3. 47) μg/ml,all P〈0. 05]. The rate of recurrence in experimental group was lower than that in control group(6. 25% vs 25. 00%,χ2= 4. 267,P = 0. 039). Conclusion Using Raltitrexed in intra-operative peritoneal lavage has a significant effect on preventing recurrence after radical resection of colorectal carcinoma,which could decrease the levels of serum VEGF,OPN,CEA and CA-199 and one-year recurrence rate.
作者 张红彬 李蜀华 曹万龙 ZHANG Hong-bin;LI Shu-hua;CAO Wan-long(General Surgery Department, Zigong First People's Hospital, Zigong, Sichuan 643000, Chin)
出处 《中国临床研究》 CAS 2018年第4期521-523,共3页 Chinese Journal of Clinical Research
关键词 雷替曲塞 腹腔灌洗 结直肠癌根治术 复发 血管内皮生长因子 骨桥蛋白 癌胚抗原 糖类抗原199 Raltitrexed Peritoneal lavage Radical resection of colorectal carcinoma Recurrence Vascular endothelial growth factor Osteopontin Carcino-embryonic antigen Carbohydrate antigen-199
  • 相关文献

参考文献15

二级参考文献106

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2高德荣,韩雅玲,温珍平,冯铁虹,李红,王磊.门冬氨酸钾镁与葡萄糖酸钙联用防治奥沙利铂神经毒性的临床观察[J].现代肿瘤医学,2007,15(3):417-418. 被引量:16
  • 3张弘纲,李进,秦叔逵,张燕军,宋恕平,储大同.国产伊立替康加5-氟尿嘧啶加亚叶酸钙联合沙利度胺治疗晚期大肠癌的随机对照研究[J].中华肿瘤杂志,2007,29(3):228-231. 被引量:16
  • 4Kemeny N, Garay CA, Gurtler J, et al. Randomized multicenter phase II trail of bolus plus infusional flu- orouracil/leucovorin compared with fluorouracil/leu-covorin plus oxaliplatin as third-line treatment of pa- tients with ~ advanced colorectal caneer[J]. J Clin 0n- col,2004,22(23) :4753-4761.
  • 5Saltz LB,Cox JV,Blanke C,et al. Irinotecan plus flu- orouracil and leucovorin for metastatic colorectal canc- er. Irinotecan Study Group[J]. N Engl J Med, 2000, 343(13) : 905-914.
  • 6Cocconi G,Cunningham D, Van Cutsem E,et al. Open, randomized, multicenter trail of raltitrexed versus flu- orouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Canc- er Study Group[J]. J Clin Oocol, 1998,16 (9) :2943- 2952.
  • 7Maughan T,James R,Kerr D,et al. Excess treatment related deaths and impaired quality of life show raltit- rexed is inferior to infusional 5FU regimen in the pal- liative chemotherapy of advanced colorectal cancer (CRC): final results of MRC CR06[J]. Ann oncol, 2000,11 (Supp| 4) : 1850.
  • 8Pazdur R,Vincen M. Raltitrexed (Tomudex) versus 5- fluorouracil and leucovorin (5-FU-k LV) in patients with advanced colorectal cancer (ACC) :results of a randomized , multicenter, North American trial[-C]. Denver: Proc Am Soc, 1997 : 801.
  • 9Carnaghi C, Rimassa L, Garassino I, et al. Irinotecan and raltitrexed: an active combination in advanced colorectal cancer[J].Ann Oncol, 2002,13 (9) : 1424-9.
  • 10Feliu J, Salud A, Escudero P, et al. Irinotecan plus raltitrexed as first-line treatment in advanced colorec- tal eaneer~ a phase II study[J]. Br J Cancer,2004,90 (8):1502-7.

共引文献118

同被引文献44

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部